Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
2.
Arq. ciências saúde UNIPAR ; 27(5): 2390-2406, 2023.
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1434205

RESUMO

Introduction: Human fascioliasis is a plant-borne and water-borne infection caused by the trematodes Fasciola hepatica and Fasciola gigantica. It is one of the main neglected tropical diseases, and infections in humans occur via the ingestion of contaminated water and food. This study reviews all the recorded cases of human fascioliasis in Brazil under different climatic conditions in the national territory. Methodology:A survey of human fascioliasis cases in Brazil was carried out using the Google Scholar, Lilacs and PubMed databases. The climatic variables such as temperature, precipitation, moisture and altitude were obtained from the database of the Instituto Nacional de Meteorologia (INMET). Results: Between the years 1958 and 2022, sixty-six cases of human fascioliasis were recorded in places with temperature levels between 22 °C to 33 °C, humidity 78% to 86%, precipitation 90 mm to 167 mm, and at an altitude of 16 to 935 meters above sea level. Conclusion: The parasite's ability to adapt to different climatic conditions is observed in Brazil and the number of cases of human fascioliasis in the national territory may be higher due to underreporting related to the difficulty in diagnosing the infection.


Introdução: A fasciolíase humana é uma infecção de origem vegetal e hídrica, causada pelos trematódeos Fasciola hepatica e Fasciola gigantica. É uma das principais doenças tropicais negligenciadas, e as infecções em humanos ocorrem através da ingestão de água e alimentos contaminados. Este estudo revisa todos os casos registrados de fasciolíase humana no Brasil sob diferentes condições climáticas no território nacional. Metodologia: Um levantamento dos casos de fasciolíase humana no Brasil foi realizado nas bases de dados Google Scholar, Lilacs e PubMed. As variáveis climáticas como temperatura, precipitação, umidade e altitude foram obtidas do banco de dados do Instituto Nacional de Meteorologia (INMET). Resultados: Entre os anos de 1958 e 2022, sessenta e seis casos de fasciolíase humana foram registrados em locais com níveis de temperatura entre 22 °C a 33 °C, umidade de 78% a 86%, precipitação de 90 mm a 167 mm e altitude de 16 a 935 metros acima do nível do mar. Conclusão: A capacidade de adaptação do parasito a diferentes condições climáticas é observada no Brasil e o número de casos de fasciolíase humana no território nacional pode ser maior devido à subnotificação relacionada à dificuldade de diagnóstico da infecção.


Introducción: La fascioliasis humana es una infección de origen vegetal y acuático, causada por los trematodos Fasciola hepatica y Fasciola gigantica. Es una de las principales enfermedades tropicales desatendidas, y las infecciones en humanos ocurren a través de la ingestión de agua y alimentos contaminados. Este estudio revisa todos los casos registrados de fascioliasis humana en Brasil bajo diferentes condiciones climáticas en el territorio nacional. Metodología: Se realizó una encuesta de casos de fascioliasis humana en Brasil utilizando las bases de datos Google Scholar, Lilacs y PubMed. Las variables climáticas como temperatura, precipitación, humedad y altitud se obtuvieron de la base de datos del Instituto Nacional de Meteorología (INMET). Resultados: Entre los años 1958 y 2022 se registraron sesenta y seis casos de fascioliasis humana en lugares con temperatura entre 22 °C a 33 °C, humedad entre 78% y 86%, precipitación entre 90 mm y 167 mm y una altitud de 16 a 935 metros sobre el nivel del mar. Conclusión: La capacidad de adaptación del parásito a diferentes condiciones climáticas se observa en Brasil y el número de casos de fascioliasis humana en el territorio nacional puede ser mayor debido al subregistro relacionado con la dificultad en el diagnóstico de la infección.

3.
Rev. Soc. Bras. Med. Trop ; 56: e0661, 2023. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1422873

RESUMO

ABSTRACT Introduction: Immunogenicity has emerged as a challenge in the development of vaccines against coronavirus disease of 2019 (COVID-19). Immunogenicity is a determinant of the efficacy and safety of vaccines. This systematic review and associated meta-analysis summarized and characterized the immunogenicity of COVID-19 vaccines in randomized controlled trials (RCTs). Methods: Relevant RCTs were systematically sourced from different medical databases in August 2021. The risk ratios and mean differences with 95% confidence intervals were calculated. Results: Of 2,310 papers, 16 RCTs were eligible for review. These RCTs involved a total of 26,698 participants (15,292 males and 11,231 females). The pooled results showed a significant difference in the geometric mean titer between the vaccinated and control groups in favor of the vaccine group after 1 and 2 months of follow-up, for the young age group (18 - < 55y), and with different doses (P < 0.001). The difference in the older age group (>55y) was insignificant (P = 0.24). The seroconversion rate of spike neutralizing antibodies favored the vaccine groups 1 or 2 months after vaccination (P < 0.001). The seroconversion rate of the vaccine group was significantly different (P < 0.001) from that of the control group. Conclusions: Vaccination elicits immunogenicity in the follow-up period for all age groups and at low and large doses. Therefore, people should be encouraged to receive vaccines currently being offered. A boost dose has been asserted for the elderly.

4.
Rev. Soc. Bras. Med. Trop ; 55: e0113, 2022. graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1406999

RESUMO

ABSTRACT Background: This study is the first report of the species Panstrongylus rufotuberculatus in Roraima, a state in northern Brazil. Methods: We collected specimens from a residence in the municipality of Rorainópolis. Results: Our findings confirmed the occurrence of this species in Roraima, increasing the number of registered species from six to seven. Conclusions: Future studies are required to further investigate and expand our knowledge of the occurrence of this species and its epidemiological importance for this state.

5.
Rev. Soc. Bras. Med. Trop ; 55: e0687, 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1394688

RESUMO

ABSTRACT Background: Chagas disease is gaining importance in the Brazilian Amazon region as a differential diagnosis of febrile syndrome. The most recent microoutbreak occurred in Ipixuna, in Amazonas state. Methods: An epidemiological survey was conducted using parasitological and serological tests, and electrocardiographic analysis. Results: The patients belonged to one family and had ingested açaí acquired from Ipixuna. All patients reported fever and initially a thick blood smear test was done to identify Trypanosoma cruzi. Benznidazole treatment was administered to all patients. Conclusions: Knowledge of the epidemiological dynamics of Chagas disease allows us to improve control and management measures for this disease.

7.
Rev. Soc. Bras. Med. Trop ; 54: e20200012, 2021. graf
Artigo em Inglês | SES-SP, ColecionaSUS, LILACS | ID: biblio-1136924

RESUMO

Abstract Ramsay Hunt Syndrome (RHS), also known as herpes zoster oticus, is caused by the reactivation of varicella zoster virus (VZV) in the geniculate ganglion of the facial nerve. Herein, we report a case of Ramsey Hunt Syndrome in a patient after antimonial treatment for Cutaneous Leishmaniasis. The patient presented with microvesicles grouped on an erythematous base, starting in the neck and ascending towards the scalp margin on the right side of the head. The patient also developed grade V peripheral facial palsy the day after initiating the herpes zoster treatment, this outcome corroborated the assumption of Ramsey Hunt Syndrome.


Assuntos
Humanos , Leishmaniose Cutânea/tratamento farmacológico , Herpes Zoster da Orelha Externa/terapia , Herpes Zoster , Estados Unidos , Herpesvirus Humano 3
8.
Rev. Soc. Bras. Med. Trop ; 54: e0873-2020, 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1155567

RESUMO

Abstract Chagas disease is caused by the protozoan Trypanosoma cruzi. Seven lineages have been identified based on different molecular markers, namely TcI, TcII, TcIII, TcIV, TcV, TcVI, and TcBat. Dogs play the role of epidemiological sentinels being domestic reservoirs of T. cruzi. The aim of the current study was to report the first case of CD in a domestic dog in Manaus, Amazonas, Brazil, infected with T. cruzi DTU TcIV. We hope our report encourages veterinarians and surveillance professionals to a take a deeper look at T. cruzi infection in domestic animals.


Assuntos
Animais , Cães , Trypanosoma cruzi/genética , Doença de Chagas/diagnóstico , Doença de Chagas/veterinária , Brasil , Genótipo
9.
Rev. Soc. Bras. Med. Trop ; 54: e0480-2020, 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1155588

RESUMO

Abstract Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has long been considered a non-endemic area for CD; however, in the last decades, with an increase in the number of acute and chronic cases, disease evolution has received greater attention. Here, we report the successful implementation of a cardioverter-defibrillator for the prevention of sudden death in a patient with autochthonous Chagas cardiomyopathy in the Brazilian Amazon.


Assuntos
Humanos , Cardiomiopatia Chagásica/complicações , Desfibriladores Implantáveis , Brasil , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia
10.
Rev. Soc. Bras. Med. Trop ; 54: e0633-2020, 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1155602

RESUMO

Abstract In this study, we present two cases of cutaneous leishmaniasis in patients with end-stage renal disease, who were treated solely with intramuscular pentamidine. In such cases, treatment implies a fine line between therapeutic efficacy and toxicity. This is suggestive of a knowledge gap; however, findings indicate that this is still the fastest and safest alternative to the treatment with antimonials. Also, it can help avoid the side effects that occur upon using antimonials.


Assuntos
Humanos , Leishmaniose Cutânea/complicações , Leishmaniose Cutânea/tratamento farmacológico , Falência Renal Crônica/complicações , Falência Renal Crônica/terapia , Antiprotozoários/uso terapêutico , Pentamidina/uso terapêutico , Diálise Renal
12.
Arq. bras. cardiol ; 112(3): 240-246, Mar. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-989336

RESUMO

Abstract Background: In the past two decades, a new epidemiological profile of Chagas' disease (CD) has been registered in the Brazilian Amazon where oral transmission has been indicated as responsible for the increase of acute cases. In the Amazonas state, five outbreaks of acute CD have been registered since 2004. The cardiac manifestations in these cases may be characterized by diffuse myocarditis, with alteration in the electrocardiogram (ECG) and transthoracic echocardiogram (TTE). Objective: To perform a cardiac evaluation in autochthonous patients in the acute phase and at least one year after submitted to treatment for acute CD and evaluate the demographic variables associated with the presence of cardiac alterations. Methods: We evaluated patients diagnosed with acute CD through direct parasitological or serological (IgM) methods from 2007 to 2015. These patients were treated with benznidazole and underwent ECG and TTE before and after treatment. We assumed a confidence interval of 95% (CI 95%, p < 0.05) for all variables analyzed. Results: We observed 63 cases of an acute CD in which oral transmission corresponded to 75%. Cardiac alterations were found in 33% of the cases, with a greater frequency of ventricular repolarization alteration (13%), followed by pericardial effusion (10%) and right bundle branch block and left anterior fascicular block (2%). The follow-up occurred in 48 patients with ECG and 25 with TTE for a mean period of 15.5 ± 4.1 months after treatment. Of these, 8% presented normalization of the cardiac alterations in ECG, 62.5% remained with the normal exams. All of the patients presented normal results in TTE in the post-treatment period. As for the demographic variables, isolated cases presented more cardiac alterations than outbreaks (p = 0.044) as well as cases from Central Amazonas mesoregion (p = 0.020). Conclusions: Although cardiac alterations have not been frequent in most of the studied population, a continuous evaluation of the clinical-epidemiological dynamics of the disease in the region is necessary in order to establish preventive measures.


Resumo Fundamento: Nas últimas duas décadas, um novo perfil epidemiológico da Doença de Chagas (DC) foi registrado na Amazônia brasileira, onde a transmissão oral foi indicada como responsável pelo aumento dos casos agudos. No estado do Amazonas, foram registrados cinco surtos da doença desde 2004. As manifestações cardíacas nesses casos podem ser caracterizadas por miocardite difusa, com alteração nos resultados eletrocardiograma (ECG) e ecocardiografia transtorácica (ETT). Objetivo: avaliar parâmetros cardíacos em pacientes autóctones com DC na fase aguda e em um ano ou mais após tratamento, e avaliar as variáveis demográficas associadas com a presença de alterações cardíacas. Métodos: Avaliamos os pacientes diagnosticados com DC aguda por método direto parasitológico e exame sorológico (IgM) entre 2007 e 2015. Os pacientes foram tratados com benzonidazol e submetidos à ECG e ETT antes e após tratamento. Assumimos um intervalo de confiança de 95% (p < 0,05) para todas as variáveis analisadas. Resultados: Observamos 63 casos de DC aguda em que a transmissão oral ocorreu em 75% dos casos. Alterações cardíacas foram encontradas em 33% dos casos, com maior frequência de repolarização ventricular (13%), seguida de derrame pericárdico (10%), e bloqueio do ramo direito e bloqueio fascicular anterior esquerdo (2%). O acompanhamento foi realizado com 48 pacientes com ECG e 25 com ETT por um período médio de 15,5±4,1 meses após o tratamento. Desses pacientes, observou-se normalização das alterações eletrocardiográficas em 8% dos pacientes, e 62,5% continuaram com os parâmetros normais. Todos os pacientes apresentaram resultados da ETT normais no período pós-tratamento. Quanto às variáveis demográficas, os casos isolados apresentaram mais alterações cardíacas em comparação aos casos de surtos (p=0,044) e os casos identificados na mesorregião do Amazonas Central (p = 0,020). Conclusões: Apesar de as alterações cardíacas não terem sido frequentes na maioria da população do estudo, é necessária uma avaliação contínua da dinâmica clínica-epidemiológica da doença na região para se estabelecer medidas preventivas.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Adulto Jovem , Tripanossomicidas/uso terapêutico , Cardiomiopatia Chagásica/parasitologia , Doença de Chagas/tratamento farmacológico , Nitroimidazóis/uso terapêutico , Trypanosoma cruzi/isolamento & purificação , Brasil/epidemiologia , Ecocardiografia , Cardiomiopatia Chagásica/diagnóstico por imagem , Seguimentos , Doença de Chagas/complicações , Doença de Chagas/epidemiologia , Eletrocardiografia
13.
Rev. Soc. Bras. Med. Trop ; 51(6): 869-872, Nov.-Dec. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-977102

RESUMO

Abstract Cardiorenal syndrome type 1 (CRS 1) occurs when acute heart failure leads to acute kidney injury. There are several etiologies of CRS 1, including Chagas disease. Here, we present the first case report of CRS 1 in a patient with acute Chagas disease. Electrocardiography, transthoracic echocardiography, and cardiac magnetic resonance imaging showed signs of acute myocarditis. Laboratory examination revealed severe loss of kidney function, with a creatinine clearance of 30 mL/min, which fully normalized after treatment. Due to emergence of Chagas disease in the Brazilian Amazon, it is important to report unique clinical features in order to improve patients' outcomes.


Assuntos
Humanos , Masculino , Adulto , Doença de Chagas/complicações , Síndrome Cardiorrenal/parasitologia , Imageamento por Ressonância Magnética , Ecocardiografia , Doença Aguda , Eletrocardiografia , Síndrome Cardiorrenal/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA